vs
Side-by-side financial comparison of Medline Inc. (MDLN) and Orchestra BioMed Holdings, Inc. (OBIO). Click either name above to swap in a different company.
Medline Inc. is an American public healthcare company headquartered in Northfield, Illinois. In June 2021 it was acquired by a consortium of private equity firms Blackstone, Carlyle and Hellman & Friedman valuing the company at $34 billion in one of the largest leveraged buyouts of all time. It was the nation's largest privately held manufacturer and distributor of medical supplies providing products, education, clinical programs and services across the continuum of care with operations in ov...
Orchestra BioMed Holdings, Inc. is a clinical-stage medical technology company focused on developing novel, evidence-based therapeutic solutions for cardiovascular and other high-burden chronic diseases. It collaborates with leading healthcare stakeholders, operates primarily across North American and European markets, with core segments covering interventional cardiology and chronic disease care optimization.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $30.9M | ||
| Q3 25 | — | $861.0K | ||
| Q2 25 | — | $836.0K | ||
| Q1 25 | — | $868.0K | ||
| Q4 24 | — | $253.0K | ||
| Q3 24 | — | $987.0K | ||
| Q2 24 | — | $778.0K | ||
| Q1 24 | — | $620.0K |
| Q4 25 | — | $6.2M | ||
| Q3 25 | — | $-20.8M | ||
| Q2 25 | — | $-19.4M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-16.2M | ||
| Q3 24 | — | $-15.4M | ||
| Q2 24 | — | $-16.0M | ||
| Q1 24 | — | $-13.5M |
| Q4 25 | — | 99.8% | ||
| Q3 25 | — | 94.3% | ||
| Q2 25 | — | 94.5% | ||
| Q1 25 | — | 94.9% | ||
| Q4 24 | — | 77.1% | ||
| Q3 24 | — | 93.1% | ||
| Q2 24 | — | 94.3% | ||
| Q1 24 | — | 94.5% |
| Q4 25 | — | 21.8% | ||
| Q3 25 | — | -2359.2% | ||
| Q2 25 | — | -2311.8% | ||
| Q1 25 | — | -2179.8% | ||
| Q4 24 | — | -6591.7% | ||
| Q3 24 | — | -1655.7% | ||
| Q2 24 | — | -2167.0% | ||
| Q1 24 | — | -2326.3% |
| Q4 25 | — | 20.2% | ||
| Q3 25 | — | -2419.0% | ||
| Q2 25 | — | -2316.1% | ||
| Q1 25 | — | -2160.7% | ||
| Q4 24 | — | -6385.4% | ||
| Q3 24 | — | -1562.9% | ||
| Q2 24 | — | -2054.0% | ||
| Q1 24 | — | -2171.5% |
| Q4 25 | — | $0.28 | ||
| Q3 25 | — | $-0.40 | ||
| Q2 25 | — | $-0.50 | ||
| Q1 25 | — | $-0.49 | ||
| Q4 24 | — | $-0.42 | ||
| Q3 24 | — | $-0.41 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.38 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
